Correlation Between Genetic Technologies and Pointsbet Holdings

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Genetic Technologies and Pointsbet Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genetic Technologies and Pointsbet Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genetic Technologies and Pointsbet Holdings, you can compare the effects of market volatilities on Genetic Technologies and Pointsbet Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genetic Technologies with a short position of Pointsbet Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genetic Technologies and Pointsbet Holdings.

Diversification Opportunities for Genetic Technologies and Pointsbet Holdings

-0.36
  Correlation Coefficient

Very good diversification

The 3 months correlation between Genetic and Pointsbet is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Genetic Technologies and Pointsbet Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pointsbet Holdings and Genetic Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genetic Technologies are associated (or correlated) with Pointsbet Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pointsbet Holdings has no effect on the direction of Genetic Technologies i.e., Genetic Technologies and Pointsbet Holdings go up and down completely randomly.

Pair Corralation between Genetic Technologies and Pointsbet Holdings

Assuming the 90 days trading horizon Genetic Technologies is expected to under-perform the Pointsbet Holdings. But the stock apears to be less risky and, when comparing its historical volatility, Genetic Technologies is 3.67 times less risky than Pointsbet Holdings. The stock trades about -0.04 of its potential returns per unit of risk. The Pointsbet Holdings is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest  67.00  in Pointsbet Holdings on October 8, 2024 and sell it today you would earn a total of  33.00  from holding Pointsbet Holdings or generate 49.25% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Genetic Technologies  vs.  Pointsbet Holdings

 Performance 
       Timeline  
Genetic Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Genetic Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Genetic Technologies is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Pointsbet Holdings 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Pointsbet Holdings are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain technical indicators, Pointsbet Holdings unveiled solid returns over the last few months and may actually be approaching a breakup point.

Genetic Technologies and Pointsbet Holdings Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Genetic Technologies and Pointsbet Holdings

The main advantage of trading using opposite Genetic Technologies and Pointsbet Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genetic Technologies position performs unexpectedly, Pointsbet Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pointsbet Holdings will offset losses from the drop in Pointsbet Holdings' long position.
The idea behind Genetic Technologies and Pointsbet Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance